Global Decitabine for Injection Market Growth 2024-2030

Product Code: 1211445

Industry: Pharma & Healthcare

Published: Jul 28,2024

Pages: 97

Delivery Time: 2-3 business days

Global Decitabine for Injection Market Growth 2024-2030

Product Code: 1211445

Industry: Pharma & Healthcare

Published: Jul 28,2024

Pages: 97

Delivery Time: 2-3 business days

Select A Format

Single User License

USD3660

Multi Users License

USD5490

Corporate Users License

USD7320

Buy Now

Add To Cart

Or More Options：

PDF Download

Sample Request

Custom Request

Provide market analysis and obtain sources of data reports

Description

The global Decitabine for Injection market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “Decitabine for Injection Industry Forecast” looks at past sales and reviews total world Decitabine for Injection sales in 2023, providing a comprehensive analysis by region and market sector of projected Decitabine for Injection sales for 2024 through 2030. With Decitabine for Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Decitabine for Injection industry.

This Insight Report provides a comprehensive analysis of the global Decitabine for Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Decitabine for Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Decitabine for Injection market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Decitabine for Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Decitabine for Injection.

United States market for Decitabine for Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Decitabine for Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Decitabine for Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Decitabine for Injection players cover Otsuka US, Sagent Pharmaceuticals, Astex Pharmaceuticals, Meitheal Pharmaceuticals, Chia Tai Tianqing Pharmaceutical Group, etc. In terms of revenue, the global two largest companies occupied for a share nearly 
 % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Decitabine for Injection market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
    50mg/Bottle
    Other

Segmentation by Application:
    Hospital
    Clinic

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

    Otsuka US
    Sagent Pharmaceuticals
    Astex Pharmaceuticals
    Meitheal Pharmaceuticals
    Chia Tai Tianqing Pharmaceutical Group
    Hansoh Pharmaceutical
    Ingenus Pharmaceutical
    Xian Janssen Pharmaceutical
    Huiyu Pharmaceutical
    Qilu Pharmaceutical

Key Questions Addressed in this Report
What is the 10-year outlook for the global Decitabine for Injection market?
What factors are driving Decitabine for Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Decitabine for Injection market opportunities vary by end market size?
How does Decitabine for Injection break out by Type, by Application?

Table Of Contents

1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
    1.8 Market Estimation Caveats

2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Decitabine for Injection Annual Sales 2019-2030
        2.1.2 World Current & Future Analysis for Decitabine for Injection by Geographic Region, 2019, 2023 & 2030
        2.1.3 World Current & Future Analysis for Decitabine for Injection by Country/Region, 2019, 2023 & 2030
    2.2 Decitabine for Injection Segment by Type
        2.2.1 50mg/Bottle
        2.2.2 Other
    2.3 Decitabine for Injection Sales by Type
        2.3.1 Global Decitabine for Injection Sales Market Share by Type (2019-2024)
        2.3.2 Global Decitabine for Injection Revenue and Market Share by Type (2019-2024)
        2.3.3 Global Decitabine for Injection Sale Price by Type (2019-2024)
    2.4 Decitabine for Injection Segment by Application
        2.4.1 Hospital
        2.4.2 Clinic
    2.5 Decitabine for Injection Sales by Application
        2.5.1 Global Decitabine for Injection Sale Market Share by Application (2019-2024)
        2.5.2 Global Decitabine for Injection Revenue and Market Share by Application (2019-2024)
        2.5.3 Global Decitabine for Injection Sale Price by Application (2019-2024)

3 Global by Company
    3.1 Global Decitabine for Injection Breakdown Data by Company
        3.1.1 Global Decitabine for Injection Annual Sales by Company (2019-2024)
        3.1.2 Global Decitabine for Injection Sales Market Share by Company (2019-2024)
    3.2 Global Decitabine for Injection Annual Revenue by Company (2019-2024)
        3.2.1 Global Decitabine for Injection Revenue by Company (2019-2024)
        3.2.2 Global Decitabine for Injection Revenue Market Share by Company (2019-2024)
    3.3 Global Decitabine for Injection Sale Price by Company
    3.4 Key Manufacturers Decitabine for Injection Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers Decitabine for Injection Product Location Distribution
        3.4.2 Players Decitabine for Injection Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
    3.6 New Products and Potential Entrants
    3.7 Market M&A Activity & Strategy

4 World Historic Review for Decitabine for Injection by Geographic Region
    4.1 World Historic Decitabine for Injection Market Size by Geographic Region (2019-2024)
        4.1.1 Global Decitabine for Injection Annual Sales by Geographic Region (2019-2024)
        4.1.2 Global Decitabine for Injection Annual Revenue by Geographic Region (2019-2024)
    4.2 World Historic Decitabine for Injection Market Size by Country/Region (2019-2024)
        4.2.1 Global Decitabine for Injection Annual Sales by Country/Region (2019-2024)
        4.2.2 Global Decitabine for Injection Annual Revenue by Country/Region (2019-2024)
    4.3 Americas Decitabine for Injection Sales Growth
    4.4 APAC Decitabine for Injection Sales Growth
    4.5 Europe Decitabine for Injection Sales Growth
    4.6 Middle East & Africa Decitabine for Injection Sales Growth

5 Americas
    5.1 Americas Decitabine for Injection Sales by Country
        5.1.1 Americas Decitabine for Injection Sales by Country (2019-2024)
        5.1.2 Americas Decitabine for Injection Revenue by Country (2019-2024)
    5.2 Americas Decitabine for Injection Sales by Type (2019-2024)
    5.3 Americas Decitabine for Injection Sales by Application (2019-2024)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil

6 APAC
    6.1 APAC Decitabine for Injection Sales by Region
        6.1.1 APAC Decitabine for Injection Sales by Region (2019-2024)
        6.1.2 APAC Decitabine for Injection Revenue by Region (2019-2024)
    6.2 APAC Decitabine for Injection Sales by Type (2019-2024)
    6.3 APAC Decitabine for Injection Sales by Application (2019-2024)
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan

7 Europe
    7.1 Europe Decitabine for Injection by Country
        7.1.1 Europe Decitabine for Injection Sales by Country (2019-2024)
        7.1.2 Europe Decitabine for Injection Revenue by Country (2019-2024)
    7.2 Europe Decitabine for Injection Sales by Type (2019-2024)
    7.3 Europe Decitabine for Injection Sales by Application (2019-2024)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia

8 Middle East & Africa
    8.1 Middle East & Africa Decitabine for Injection by Country
        8.1.1 Middle East & Africa Decitabine for Injection Sales by Country (2019-2024)
        8.1.2 Middle East & Africa Decitabine for Injection Revenue by Country (2019-2024)
    8.2 Middle East & Africa Decitabine for Injection Sales by Type (2019-2024)
    8.3 Middle East & Africa Decitabine for Injection Sales by Application (2019-2024)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries

9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends

10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of Decitabine for Injection
    10.3 Manufacturing Process Analysis of Decitabine for Injection
    10.4 Industry Chain Structure of Decitabine for Injection

11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 Decitabine for Injection Distributors
    11.3 Decitabine for Injection Customer

12 World Forecast Review for Decitabine for Injection by Geographic Region
    12.1 Global Decitabine for Injection Market Size Forecast by Region
        12.1.1 Global Decitabine for Injection Forecast by Region (2025-2030)
        12.1.2 Global Decitabine for Injection Annual Revenue Forecast by Region (2025-2030)
    12.2 Americas Forecast by Country (2025-2030)
    12.3 APAC Forecast by Region (2025-2030)
    12.4 Europe Forecast by Country (2025-2030)
    12.5 Middle East & Africa Forecast by Country (2025-2030)
    12.6 Global Decitabine for Injection Forecast by Type (2025-2030)
    12.7 Global Decitabine for Injection Forecast by Application (2025-2030)

13 Key Players Analysis
    13.1 Otsuka US
        13.1.1 Otsuka US Company Information
        13.1.2 Otsuka US Decitabine for Injection Product Portfolios and Specifications
        13.1.3 Otsuka US Decitabine for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
        13.1.4 Otsuka US Main Business Overview
        13.1.5 Otsuka US Latest Developments
    13.2 Sagent Pharmaceuticals
        13.2.1 Sagent Pharmaceuticals Company Information
        13.2.2 Sagent Pharmaceuticals Decitabine for Injection Product Portfolios and Specifications
        13.2.3 Sagent Pharmaceuticals Decitabine for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
        13.2.4 Sagent Pharmaceuticals Main Business Overview
        13.2.5 Sagent Pharmaceuticals Latest Developments
    13.3 Astex Pharmaceuticals
        13.3.1 Astex Pharmaceuticals Company Information
        13.3.2 Astex Pharmaceuticals Decitabine for Injection Product Portfolios and Specifications
        13.3.3 Astex Pharmaceuticals Decitabine for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
        13.3.4 Astex Pharmaceuticals Main Business Overview
        13.3.5 Astex Pharmaceuticals Latest Developments
    13.4 Meitheal Pharmaceuticals
        13.4.1 Meitheal Pharmaceuticals Company Information
        13.4.2 Meitheal Pharmaceuticals Decitabine for Injection Product Portfolios and Specifications
        13.4.3 Meitheal Pharmaceuticals Decitabine for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
        13.4.4 Meitheal Pharmaceuticals Main Business Overview
        13.4.5 Meitheal Pharmaceuticals Latest Developments
    13.5 Chia Tai Tianqing Pharmaceutical Group
        13.5.1 Chia Tai Tianqing Pharmaceutical Group Company Information
        13.5.2 Chia Tai Tianqing Pharmaceutical Group Decitabine for Injection Product Portfolios and Specifications
        13.5.3 Chia Tai Tianqing Pharmaceutical Group Decitabine for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
        13.5.4 Chia Tai Tianqing Pharmaceutical Group Main Business Overview
        13.5.5 Chia Tai Tianqing Pharmaceutical Group Latest Developments
    13.6 Hansoh Pharmaceutical
        13.6.1 Hansoh Pharmaceutical Company Information
        13.6.2 Hansoh Pharmaceutical Decitabine for Injection Product Portfolios and Specifications
        13.6.3 Hansoh Pharmaceutical Decitabine for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
        13.6.4 Hansoh Pharmaceutical Main Business Overview
        13.6.5 Hansoh Pharmaceutical Latest Developments
    13.7 Ingenus Pharmaceutical
        13.7.1 Ingenus Pharmaceutical Company Information
        13.7.2 Ingenus Pharmaceutical Decitabine for Injection Product Portfolios and Specifications
        13.7.3 Ingenus Pharmaceutical Decitabine for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
        13.7.4 Ingenus Pharmaceutical Main Business Overview
        13.7.5 Ingenus Pharmaceutical Latest Developments
    13.8 Xian Janssen Pharmaceutical
        13.8.1 Xian Janssen Pharmaceutical Company Information
        13.8.2 Xian Janssen Pharmaceutical Decitabine for Injection Product Portfolios and Specifications
        13.8.3 Xian Janssen Pharmaceutical Decitabine for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
        13.8.4 Xian Janssen Pharmaceutical Main Business Overview
        13.8.5 Xian Janssen Pharmaceutical Latest Developments
    13.9 Huiyu Pharmaceutical
        13.9.1 Huiyu Pharmaceutical Company Information
        13.9.2 Huiyu Pharmaceutical Decitabine for Injection Product Portfolios and Specifications
        13.9.3 Huiyu Pharmaceutical Decitabine for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
        13.9.4 Huiyu Pharmaceutical Main Business Overview
        13.9.5 Huiyu Pharmaceutical Latest Developments
    13.10 Qilu Pharmaceutical
        13.10.1 Qilu Pharmaceutical Company Information
        13.10.2 Qilu Pharmaceutical Decitabine for Injection Product Portfolios and Specifications
        13.10.3 Qilu Pharmaceutical Decitabine for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
        13.10.4 Qilu Pharmaceutical Main Business Overview
        13.10.5 Qilu Pharmaceutical Latest Developments

14 Research Findings and Conclusion

List Of Tables

List of Tables
 Table 1. Decitabine for Injection Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
 Table 2. Decitabine for Injection Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
 Table 3. Major Players of 50mg/Bottle
 Table 4. Major Players of Other
 Table 5. Global Decitabine for Injection Sales by Type (2019-2024) & (K Units)
 Table 6. Global Decitabine for Injection Sales Market Share by Type (2019-2024)
 Table 7. Global Decitabine for Injection Revenue by Type (2019-2024) & ($ million)
 Table 8. Global Decitabine for Injection Revenue Market Share by Type (2019-2024)
 Table 9. Global Decitabine for Injection Sale Price by Type (2019-2024) & (US$/Unit)
 Table 10. Global Decitabine for Injection Sale by Application (2019-2024) & (K Units)
 Table 11. Global Decitabine for Injection Sale Market Share by Application (2019-2024)
 Table 12. Global Decitabine for Injection Revenue by Application (2019-2024) & ($ million)
 Table 13. Global Decitabine for Injection Revenue Market Share by Application (2019-2024)
 Table 14. Global Decitabine for Injection Sale Price by Application (2019-2024) & (US$/Unit)
 Table 15. Global Decitabine for Injection Sales by Company (2019-2024) & (K Units)
 Table 16. Global Decitabine for Injection Sales Market Share by Company (2019-2024)
 Table 17. Global Decitabine for Injection Revenue by Company (2019-2024) & ($ millions)
 Table 18. Global Decitabine for Injection Revenue Market Share by Company (2019-2024)
 Table 19. Global Decitabine for Injection Sale Price by Company (2019-2024) & (US$/Unit)
 Table 20. Key Manufacturers Decitabine for Injection Producing Area Distribution and Sales Area
 Table 21. Players Decitabine for Injection Products Offered
 Table 22. Decitabine for Injection Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
 Table 23. New Products and Potential Entrants
 Table 24. Market M&A Activity & Strategy
 Table 25. Global Decitabine for Injection Sales by Geographic Region (2019-2024) & (K Units)
 Table 26. Global Decitabine for Injection Sales Market Share Geographic Region (2019-2024)
 Table 27. Global Decitabine for Injection Revenue by Geographic Region (2019-2024) & ($ millions)
 Table 28. Global Decitabine for Injection Revenue Market Share by Geographic Region (2019-2024)
 Table 29. Global Decitabine for Injection Sales by Country/Region (2019-2024) & (K Units)
 Table 30. Global Decitabine for Injection Sales Market Share by Country/Region (2019-2024)
 Table 31. Global Decitabine for Injection Revenue by Country/Region (2019-2024) & ($ millions)
 Table 32. Global Decitabine for Injection Revenue Market Share by Country/Region (2019-2024)
 Table 33. Americas Decitabine for Injection Sales by Country (2019-2024) & (K Units)
 Table 34. Americas Decitabine for Injection Sales Market Share by Country (2019-2024)
 Table 35. Americas Decitabine for Injection Revenue by Country (2019-2024) & ($ millions)
 Table 36. Americas Decitabine for Injection Sales by Type (2019-2024) & (K Units)
 Table 37. Americas Decitabine for Injection Sales by Application (2019-2024) & (K Units)
 Table 38. APAC Decitabine for Injection Sales by Region (2019-2024) & (K Units)
 Table 39. APAC Decitabine for Injection Sales Market Share by Region (2019-2024)
 Table 40. APAC Decitabine for Injection Revenue by Region (2019-2024) & ($ millions)
 Table 41. APAC Decitabine for Injection Sales by Type (2019-2024) & (K Units)
 Table 42. APAC Decitabine for Injection Sales by Application (2019-2024) & (K Units)
 Table 43. Europe Decitabine for Injection Sales by Country (2019-2024) & (K Units)
 Table 44. Europe Decitabine for Injection Revenue by Country (2019-2024) & ($ millions)
 Table 45. Europe Decitabine for Injection Sales by Type (2019-2024) & (K Units)
 Table 46. Europe Decitabine for Injection Sales by Application (2019-2024) & (K Units)
 Table 47. Middle East & Africa Decitabine for Injection Sales by Country (2019-2024) & (K Units)
 Table 48. Middle East & Africa Decitabine for Injection Revenue Market Share by Country (2019-2024)
 Table 49. Middle East & Africa Decitabine for Injection Sales by Type (2019-2024) & (K Units)
 Table 50. Middle East & Africa Decitabine for Injection Sales by Application (2019-2024) & (K Units)
 Table 51. Key Market Drivers & Growth Opportunities of Decitabine for Injection
 Table 52. Key Market Challenges & Risks of Decitabine for Injection
 Table 53. Key Industry Trends of Decitabine for Injection
 Table 54. Decitabine for Injection Raw Material
 Table 55. Key Suppliers of Raw Materials
 Table 56. Decitabine for Injection Distributors List
 Table 57. Decitabine for Injection Customer List
 Table 58. Global Decitabine for Injection Sales Forecast by Region (2025-2030) & (K Units)
 Table 59. Global Decitabine for Injection Revenue Forecast by Region (2025-2030) & ($ millions)
 Table 60. Americas Decitabine for Injection Sales Forecast by Country (2025-2030) & (K Units)
 Table 61. Americas Decitabine for Injection Annual Revenue Forecast by Country (2025-2030) & ($ millions)
 Table 62. APAC Decitabine for Injection Sales Forecast by Region (2025-2030) & (K Units)
 Table 63. APAC Decitabine for Injection Annual Revenue Forecast by Region (2025-2030) & ($ millions)
 Table 64. Europe Decitabine for Injection Sales Forecast by Country (2025-2030) & (K Units)
 Table 65. Europe Decitabine for Injection Revenue Forecast by Country (2025-2030) & ($ millions)
 Table 66. Middle East & Africa Decitabine for Injection Sales Forecast by Country (2025-2030) & (K Units)
 Table 67. Middle East & Africa Decitabine for Injection Revenue Forecast by Country (2025-2030) & ($ millions)
 Table 68. Global Decitabine for Injection Sales Forecast by Type (2025-2030) & (K Units)
 Table 69. Global Decitabine for Injection Revenue Forecast by Type (2025-2030) & ($ millions)
 Table 70. Global Decitabine for Injection Sales Forecast by Application (2025-2030) & (K Units)
 Table 71. Global Decitabine for Injection Revenue Forecast by Application (2025-2030) & ($ millions)
 Table 72. Otsuka US Basic Information, Decitabine for Injection Manufacturing Base, Sales Area and Its Competitors
 Table 73. Otsuka US Decitabine for Injection Product Portfolios and Specifications
 Table 74. Otsuka US Decitabine for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 75. Otsuka US Main Business
 Table 76. Otsuka US Latest Developments
 Table 77. Sagent Pharmaceuticals Basic Information, Decitabine for Injection Manufacturing Base, Sales Area and Its Competitors
 Table 78. Sagent Pharmaceuticals Decitabine for Injection Product Portfolios and Specifications
 Table 79. Sagent Pharmaceuticals Decitabine for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 80. Sagent Pharmaceuticals Main Business
 Table 81. Sagent Pharmaceuticals Latest Developments
 Table 82. Astex Pharmaceuticals Basic Information, Decitabine for Injection Manufacturing Base, Sales Area and Its Competitors
 Table 83. Astex Pharmaceuticals Decitabine for Injection Product Portfolios and Specifications
 Table 84. Astex Pharmaceuticals Decitabine for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 85. Astex Pharmaceuticals Main Business
 Table 86. Astex Pharmaceuticals Latest Developments
 Table 87. Meitheal Pharmaceuticals Basic Information, Decitabine for Injection Manufacturing Base, Sales Area and Its Competitors
 Table 88. Meitheal Pharmaceuticals Decitabine for Injection Product Portfolios and Specifications
 Table 89. Meitheal Pharmaceuticals Decitabine for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 90. Meitheal Pharmaceuticals Main Business
 Table 91. Meitheal Pharmaceuticals Latest Developments
 Table 92. Chia Tai Tianqing Pharmaceutical Group Basic Information, Decitabine for Injection Manufacturing Base, Sales Area and Its Competitors
 Table 93. Chia Tai Tianqing Pharmaceutical Group Decitabine for Injection Product Portfolios and Specifications
 Table 94. Chia Tai Tianqing Pharmaceutical Group Decitabine for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 95. Chia Tai Tianqing Pharmaceutical Group Main Business
 Table 96. Chia Tai Tianqing Pharmaceutical Group Latest Developments
 Table 97. Hansoh Pharmaceutical Basic Information, Decitabine for Injection Manufacturing Base, Sales Area and Its Competitors
 Table 98. Hansoh Pharmaceutical Decitabine for Injection Product Portfolios and Specifications
 Table 99. Hansoh Pharmaceutical Decitabine for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 100. Hansoh Pharmaceutical Main Business
 Table 101. Hansoh Pharmaceutical Latest Developments
 Table 102. Ingenus Pharmaceutical Basic Information, Decitabine for Injection Manufacturing Base, Sales Area and Its Competitors
 Table 103. Ingenus Pharmaceutical Decitabine for Injection Product Portfolios and Specifications
 Table 104. Ingenus Pharmaceutical Decitabine for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 105. Ingenus Pharmaceutical Main Business
 Table 106. Ingenus Pharmaceutical Latest Developments
 Table 107. Xian Janssen Pharmaceutical Basic Information, Decitabine for Injection Manufacturing Base, Sales Area and Its Competitors
 Table 108. Xian Janssen Pharmaceutical Decitabine for Injection Product Portfolios and Specifications
 Table 109. Xian Janssen Pharmaceutical Decitabine for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 110. Xian Janssen Pharmaceutical Main Business
 Table 111. Xian Janssen Pharmaceutical Latest Developments
 Table 112. Huiyu Pharmaceutical Basic Information, Decitabine for Injection Manufacturing Base, Sales Area and Its Competitors
 Table 113. Huiyu Pharmaceutical Decitabine for Injection Product Portfolios and Specifications
 Table 114. Huiyu Pharmaceutical Decitabine for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 115. Huiyu Pharmaceutical Main Business
 Table 116. Huiyu Pharmaceutical Latest Developments
 Table 117. Qilu Pharmaceutical Basic Information, Decitabine for Injection Manufacturing Base, Sales Area and Its Competitors
 Table 118. Qilu Pharmaceutical Decitabine for Injection Product Portfolios and Specifications
 Table 119. Qilu Pharmaceutical Decitabine for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 120. Qilu Pharmaceutical Main Business
 Table 121. Qilu Pharmaceutical Latest Developments


List of Figures
 Figure 1. Picture of Decitabine for Injection
 Figure 2. Decitabine for Injection Report Years Considered
 Figure 3. Research Objectives
 Figure 4. Research Methodology
 Figure 5. Research Process and Data Source
 Figure 6. Global Decitabine for Injection Sales Growth Rate 2019-2030 (K Units)
 Figure 7. Global Decitabine for Injection Revenue Growth Rate 2019-2030 ($ millions)
 Figure 8. Decitabine for Injection Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
 Figure 9. Decitabine for Injection Sales Market Share by Country/Region (2023)
 Figure 10. Decitabine for Injection Sales Market Share by Country/Region (2019, 2023 & 2030)
 Figure 11. Product Picture of 50mg/Bottle
 Figure 12. Product Picture of Other
 Figure 13. Global Decitabine for Injection Sales Market Share by Type in 2023
 Figure 14. Global Decitabine for Injection Revenue Market Share by Type (2019-2024)
 Figure 15. Decitabine for Injection Consumed in Hospital
 Figure 16. Global Decitabine for Injection Market: Hospital (2019-2024) & (K Units)
 Figure 17. Decitabine for Injection Consumed in Clinic
 Figure 18. Global Decitabine for Injection Market: Clinic (2019-2024) & (K Units)
 Figure 19. Global Decitabine for Injection Sale Market Share by Application (2023)
 Figure 20. Global Decitabine for Injection Revenue Market Share by Application in 2023
 Figure 21. Decitabine for Injection Sales by Company in 2023 (K Units)
 Figure 22. Global Decitabine for Injection Sales Market Share by Company in 2023
 Figure 23. Decitabine for Injection Revenue by Company in 2023 ($ millions)
 Figure 24. Global Decitabine for Injection Revenue Market Share by Company in 2023
 Figure 25. Global Decitabine for Injection Sales Market Share by Geographic Region (2019-2024)
 Figure 26. Global Decitabine for Injection Revenue Market Share by Geographic Region in 2023
 Figure 27. Americas Decitabine for Injection Sales 2019-2024 (K Units)
 Figure 28. Americas Decitabine for Injection Revenue 2019-2024 ($ millions)
 Figure 29. APAC Decitabine for Injection Sales 2019-2024 (K Units)
 Figure 30. APAC Decitabine for Injection Revenue 2019-2024 ($ millions)
 Figure 31. Europe Decitabine for Injection Sales 2019-2024 (K Units)
 Figure 32. Europe Decitabine for Injection Revenue 2019-2024 ($ millions)
 Figure 33. Middle East & Africa Decitabine for Injection Sales 2019-2024 (K Units)
 Figure 34. Middle East & Africa Decitabine for Injection Revenue 2019-2024 ($ millions)
 Figure 35. Americas Decitabine for Injection Sales Market Share by Country in 2023
 Figure 36. Americas Decitabine for Injection Revenue Market Share by Country (2019-2024)
 Figure 37. Americas Decitabine for Injection Sales Market Share by Type (2019-2024)
 Figure 38. Americas Decitabine for Injection Sales Market Share by Application (2019-2024)
 Figure 39. United States Decitabine for Injection Revenue Growth 2019-2024 ($ millions)
 Figure 40. Canada Decitabine for Injection Revenue Growth 2019-2024 ($ millions)
 Figure 41. Mexico Decitabine for Injection Revenue Growth 2019-2024 ($ millions)
 Figure 42. Brazil Decitabine for Injection Revenue Growth 2019-2024 ($ millions)
 Figure 43. APAC Decitabine for Injection Sales Market Share by Region in 2023
 Figure 44. APAC Decitabine for Injection Revenue Market Share by Region (2019-2024)
 Figure 45. APAC Decitabine for Injection Sales Market Share by Type (2019-2024)
 Figure 46. APAC Decitabine for Injection Sales Market Share by Application (2019-2024)
 Figure 47. China Decitabine for Injection Revenue Growth 2019-2024 ($ millions)
 Figure 48. Japan Decitabine for Injection Revenue Growth 2019-2024 ($ millions)
 Figure 49. South Korea Decitabine for Injection Revenue Growth 2019-2024 ($ millions)
 Figure 50. Southeast Asia Decitabine for Injection Revenue Growth 2019-2024 ($ millions)
 Figure 51. India Decitabine for Injection Revenue Growth 2019-2024 ($ millions)
 Figure 52. Australia Decitabine for Injection Revenue Growth 2019-2024 ($ millions)
 Figure 53. China Taiwan Decitabine for Injection Revenue Growth 2019-2024 ($ millions)
 Figure 54. Europe Decitabine for Injection Sales Market Share by Country in 2023
 Figure 55. Europe Decitabine for Injection Revenue Market Share by Country (2019-2024)
 Figure 56. Europe Decitabine for Injection Sales Market Share by Type (2019-2024)
 Figure 57. Europe Decitabine for Injection Sales Market Share by Application (2019-2024)
 Figure 58. Germany Decitabine for Injection Revenue Growth 2019-2024 ($ millions)
 Figure 59. France Decitabine for Injection Revenue Growth 2019-2024 ($ millions)
 Figure 60. UK Decitabine for Injection Revenue Growth 2019-2024 ($ millions)
 Figure 61. Italy Decitabine for Injection Revenue Growth 2019-2024 ($ millions)
 Figure 62. Russia Decitabine for Injection Revenue Growth 2019-2024 ($ millions)
 Figure 63. Middle East & Africa Decitabine for Injection Sales Market Share by Country (2019-2024)
 Figure 64. Middle East & Africa Decitabine for Injection Sales Market Share by Type (2019-2024)
 Figure 65. Middle East & Africa Decitabine for Injection Sales Market Share by Application (2019-2024)
 Figure 66. Egypt Decitabine for Injection Revenue Growth 2019-2024 ($ millions)
 Figure 67. South Africa Decitabine for Injection Revenue Growth 2019-2024 ($ millions)
 Figure 68. Israel Decitabine for Injection Revenue Growth 2019-2024 ($ millions)
 Figure 69. Turkey Decitabine for Injection Revenue Growth 2019-2024 ($ millions)
 Figure 70. GCC Countries Decitabine for Injection Revenue Growth 2019-2024 ($ millions)
 Figure 71. Manufacturing Cost Structure Analysis of Decitabine for Injection in 2023
 Figure 72. Manufacturing Process Analysis of Decitabine for Injection
 Figure 73. Industry Chain Structure of Decitabine for Injection
 Figure 74. Channels of Distribution
 Figure 75. Global Decitabine for Injection Sales Market Forecast by Region (2025-2030)
 Figure 76. Global Decitabine for Injection Revenue Market Share Forecast by Region (2025-2030)
 Figure 77. Global Decitabine for Injection Sales Market Share Forecast by Type (2025-2030)
 Figure 78. Global Decitabine for Injection Revenue Market Share Forecast by Type (2025-2030)
 Figure 79. Global Decitabine for Injection Sales Market Share Forecast by Application (2025-2030)
 Figure 80. Global Decitabine for Injection Revenue Market Share Forecast by Application (2025-2030)

Companies Mentioned

Otsuka US

Sagent Pharmaceuticals

Astex Pharmaceuticals

Meitheal Pharmaceuticals

Chia Tai Tianqing Pharmaceutical Group

Hansoh Pharmaceutical

Ingenus Pharmaceutical

Xian Janssen Pharmaceutical

Huiyu Pharmaceutical

Qilu Pharmaceutical

Methodology

LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

Data Sourse

Primary Source

Secondary Source

Players/Suppliers

Journals and Periodicals

Industry Experts

Government Bodies

Distributors/Traders

Annual Reports

Opinion Leaders

Presentations

Front-line Staff